Cited by

• Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013).

  Brahim LR, Valete-Rosalino CM, Antônio LF, Pimentel MIF, Lyra MR, Paes LEC, Costa ADD, Vieira IF, Dias CMG, Duque MCO, Marzochi MCA, Schubach AO. Brahim LR, et al. Mem Inst Oswaldo Cruz. 2017 Dec;112(12):838-843. doi: 10.1590/0074-02760160478. Mem Inst Oswaldo Cruz. 2017. PMID: 29211245 Free PMC article.
• An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil.

  Oliveira-Ribeiro C, Pimentel MIF, Oliveira LFA, Vasconcellos ÉCFE, Conceição-Silva F, Schubach AO, Fagundes A, de Mello CX, Mouta-Confort E, Miranda LFC, Valete-Rosalino CM, Martins ACDC, Oliveira RVC, Quintella LP, Lyra MR. Oliveira-Ribeiro C, et al. PLoS Negl Trop Dis. 2021 Sep 23;15(9):e0009734. doi: 10.1371/journal.pntd.0009734. eCollection 2021 Sep. PLoS Negl Trop Dis. 2021. PMID: 34555016 Free PMC article. Clinical Trial.
• Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

  Vasconcellos Ede C, Pimentel MI, Schubach Ade O, de Oliveira Rde V, Azeredo-Coutinho RB, Silva Fda C, Salgueiro Mde M, Moreira JS, Madeira Mde F, Baptista C, Valete-Rosalino CM. Vasconcellos Ede C, et al. Am J Trop Med Hyg. 2012 Aug;87(2):257-60. doi: 10.4269/ajtmh.2012.11-0612. Am J Trop Med Hyg. 2012. PMID: 22855754 Free PMC article.
• Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil.

  Saheki MN, Lyra MR, Bedoya-Pacheco SJ, Antônio LF, Pimentel MIF, Salgueiro MM, Vasconcellos ÉCFE, Passos SRL, Santos GPLD, Ribeiro MN, Fagundes A, Madeira MF, Mouta-Confort E, Marzochi MCA, Valete-Rosalino CM, Schubach AO. Saheki MN, et al. PLoS One. 2017 May 30;12(5):e0178592. doi: 10.1371/journal.pone.0178592. eCollection 2017. PLoS One. 2017. PMID: 28558061 Free PMC article. Clinical Trial.
• Self-reporting of hearing loss and tinnitus in the diagnosis of ototoxicity by meglumine antimoniate in patients treated for American tegumentary Leishmaniasis.

  Duarte CCJ, Torraca TSS, Bezerra DO, Oliveira RB, Leite NKS, de Oliveira RVC, Araújo-Melo MH, Pimentel MIF, Costa ADD, Vasconcellos ÉCF, Lyra MR, Soares ECDA, Paes LRDNB, Salgueiro MM, Schubach AO, Valete CM. Duarte CCJ, et al. PLoS One. 2024 Feb 14;19(2):e0296728. doi: 10.1371/journal.pone.0296728. eCollection 2024. PLoS One. 2024. PMID: 38354178 Free PMC article.